
Week 16 2024 Mon 7/8-Sun 7/14 | |||||||||
Team | Coach Rating | M | T | W | T | F | S | S | Total |
---|---|---|---|---|---|---|---|---|---|
(5-13) | 29 | 26 | 36 | 18 | 10 | 27 | 33 | 179.19 | |
(8-10) | 17 | 26 | 34 | 14 | 29 | 14 | 14 | 148.62 | |
Final Division Game |
Name | Opp | Stats | Day | Total | Pos | Total | Day | Stats | Opp | Name | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
C/DH SEA | — | 27.2 | C | 5 | — | C/DH BAL | ||||||
RF/DH TOR | — | 5.5 | 1B | 14.1 | 0.8 | 0-4 AVG | 1B NYM | |||||
2B TOR | 1-3 AVG | 1.1 | 6.4 | 2B | 4.7 | 3.4 | 2-4 AVG | 2B STL | ||||
SS MIN | 1-5 AVG 1 RBI | 3.9 | 11.5 | SS | 7.5 | — | SS KC | |||||
3B COL | 2-4 AVG | 1 | 3.3 | 3B | 7.9 | 4.7 | 1-4 AVG 1 RBI | 3B ATL | ||||
RF PHI | — | 6.5 | OF | — | — | RF CHC | ||||||
LF SEA | — | 10.9 | OF | 15.1 | 2.3 | 0-2 AVG | CF CWS | |||||
CF BAL | — | 1.6 | OF | 14.4 | — | CF/DH SEA | ||||||
1B/DH MIL | — | 8.9 | UTIL | 7.7 | 0.5 | 2-4 AVG | C NYM | |||||
SP LAD | — | -1.9 | SP | 11.62 | — | SP SF | ||||||
P CIN | — | — | SP | 9.25 | — | SP CLE | ||||||
RP ATL | 2 IP | 7 | 11 | RP | 8.33 | — | P NYM | |||||
60DJ. McArthur RP KC | — | 8.1 | RP | 1.67 | — | RP CIN | ||||||
RP FA | — | 4.92 | P | 3.58 | — | RP FA | ||||||
SP PIT | 8 IP 2 ER | 16.45 | 19.45 | P | 4.25 | — | SP WSH | |||||
RP PHI | — | 2.5 | P | 12.92 | 5.67 | 1 IP | RP MIN | |||||
Total | 29.45 | 179.19 | 148.62 | 17.37 | Total | |||||||
Optimum | 29.45 | 179.83 | 145.35 | 17.37 | Optimum | |||||||
Benched | ||||||||||||
SS TOR | — | -1.8 | BN | 8.9 | — | DTDG. Torres 2B DET | ||||||
10DT. O'Neill LF/RF/DH BAL | — | -1.2 | BN | — | — | 2B BAL | ||||||
2B/3B/LF/DH TB | — | 12.3 | BN | — | — | 10DM. Harris CF ATL | ||||||
SP TOR | — | 10.72 | BN | 8.6 | — | 1B/3B/DH HOU | ||||||
SP TB | — | 28.1 | BN | 19.1 | — | SP LAA | ||||||
Total | 0 | 13.8 | 16 | 0 | Total | |||||||
Injured Reserve | ||||||||||||
DTDF. Tatis RF SD | — | — | IL | — | — | 10DE. Carter LF TEX | ||||||
15DN. Lodolo SP CIN | — | 9.84 | IL | — | — | 2B/SS/RF LAD | ||||||
RP PHI | — | — | IL | — | — | SP PHI |